The Centers for Disease Control and Prevention unveiled new guidelines Thursday for the treatment of latent tuberculosis infection in the U.S. with a 12-dose regimen, administered once-weekly under directly observed therapy. The current regimen requires daily drug administration over nine months, making the new treatment simpler and easier for patients. People with LTBI are infected […]
HIV
Progress seen in recent years against the HIV pandemic, including in rising numbers of people diagnosed and treated accompanied by dropping rates of incidence and death, […]
Tuberculosis
SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]